UNSPSC 51433930: Benidipine hydrochloride

This classification denotes a calcium channel blocker with the molecular formula C28H31N3O6.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0A6746FWDL. European Medicines Agency schedules benidipine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13004MIG. The term benidipine hydrochloride is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule benidipine hydrochloride under HS 29333999 and SITC 51574.

As of Q4 2014, BENIDIPINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Benidipine hydrochloride bears US NLM identifiers UMLS ID C0088341 and NCI Concept Code C81677. SMILES: CC1=C([C@H](C(=C(N1)C)C(=O)O[C@@H]2CCCN(C2)CC3CCCCC3)C4CCCC(C4)[N+](=O)[O-])C(=O)OC.CL.

UNSPSC 51433930 Benidipine hydrochloride is a Commodity code covering a specific antihypertensive pharmaceutical ingredient used in emergency medical services and broader state and local health care procurement. State and local governments buy this code primarily as part of Advanced Life Support medication supply contracts for emergency response agencies and as line items within larger multi-source pharmaceutical purchasing agreements supporting health care systems, correctional facilities, and public health programs. The work involves competitive bidding for pharmaceutical supply with emphasis on FDA compliance, cGMP certification, Drug Supply Chain Security Act conformance, expiration-date management, and delivery timelines tailored to emergency or routine operational needs. Issuing bodies include municipal fire departments, state health and human services agencies managing pharmacy benefit programs, and cooperative purchasing alliances administering multi-state pharmaceutical contracts on behalf of member jurisdictions.

Recent activity spans Florida, Texas, and Minnesota through cooperative vehicles. The City of Tampa's Purchasing Department issued an IFB (Solicitation 26P00188) on April 24, 2026 for Advanced Life Support Medications including Labetalol HCI, Epinephrine, Adenosine, and Diltiazem for Tampa Fire Rescue, with a response deadline of April 8, 2026 and an estimated contract value of $40,000.00 under a Small Local Business Enterprise sheltered market designation with a 5 percent bid discount. The Texas Health and Human Services Commission posted an RFI (HHS0017013) on April 3, 2026 seeking vendor capabilities for direct-to-manufacturer prescription fulfillment outside traditional pharmacy benefit manager channels, signaling state-level strategic interest in alternative distribution models. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802) on January 20, 2026 due March 26, 2026 to establish multi-award contracts for generic pharmaceuticals across participating state and local facilities including Oregon, requiring NDC-specific pricing through three authorized wholesalers with contract effectiveness July 1, 2026. Geographic concentration appears highest in the Upper Midwest and South, though cooperative purchasing vehicles such as MMCAP extend reach across multiple jurisdictions.